Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Minority Interest of $79000.0 for Q1 2026, down 20.2% on a YoY basis from $99000.0 in Q1 2025, and down 5.95% quarter-over-quarter from $84000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Minority Interest for 7 years, with the latest figure at $79000.0 in Q1 2026.
- For the quarter ending Q1 2026, Minority Interest fell 20.2% year-over-year to $79000.0; the trailing twelve-month figure through Mar 2026 stood at $79000.0 (down 20.2% YoY), and the FY2025 full-year result was $84000.0, down 20.75% from the prior year.
- Minority Interest for Q1 2026 stood at $79000.0, down from $84000.0 in the prior quarter.
- The five-year high for Minority Interest was $400000.0 in Q1 2022, with the low at $79000.0 in Q1 2026.
- Historically, Minority Interest has averaged $200764.7 across 5 years, with a median of $183000.0 in 2024.
- Annual changes were most pronounced in 2022 — Minority Interest tumbled 98.81% — and 2024, when it fell 18.54%.
- Barinthus Biotherapeutics' Minority Interest stood at $305000.0 in 2022, then sank by 30.82% to $211000.0 in 2023, then tumbled by 49.76% to $106000.0 in 2024, then slipped by 20.75% to $84000.0 in 2025, then slipped by 5.95% to $79000.0 in 2026.
- The last three Minority Interest figures came in at $79000.0 (Q1 2026), $84000.0 (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 211,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 268,000.00 |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 315,000.00 |
| Jun 30, 2022 | 366,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 437,000.00 |
| Sep 30, 2021 | 493,000.00 |
| Jun 30, 2021 | 518,000.00 |